Hit papers significantly outperform the citation benchmark for their cohort. A paper qualifies
if it has ≥500 total citations, achieves ≥1.5× the top-1% citation threshold for papers in the
same subfield and year (this is the minimum needed to enter the top 1%, not the average
within it), or reaches the top citation threshold in at least one of its specific research
topics.
How to use high-sensitivity cardiac troponins in acute cardiac care
2012523 citationsJohannes Mair, Evangelos Giannitsis et al.European Heart Journalprofile →
Peers — A (Enhanced Table)
Peers by citation overlap · career bar shows stage (early→late)
cites ·
hero ref
This map shows the geographic impact of B Lindahl's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by B Lindahl with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites B Lindahl more than expected).
This network shows the impact of papers produced by B Lindahl. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by B Lindahl. The network helps show where B Lindahl may publish in the future.
Co-authorship network of co-authors of B Lindahl
This figure shows the co-authorship network connecting the top 25 collaborators of B Lindahl.
A scholar is included among the top collaborators of B Lindahl based on the total number of
citations received by their joint publications. Widths of edges
represent the number of papers authors have co-authored together.
Node borders
signify the number of papers an author published with B Lindahl. B Lindahl is excluded from
the visualization to improve readability, since they are connected to all nodes in the network.
All Works
20 of 20 papers shown
1.
Mair, Johannes, Evangelos Giannitsis, Christian Mueller, et al.. (2012). How to use high-sensitivity cardiac troponins in acute cardiac care. European Heart Journal. 33(18). 2252–2257.523 indexed citations breakdown →
Lindahl, B, Jan Persson, Jonas Ranstam, & Roger Wïllén. (2010). Long-term survival in uterine clear cell carcinoma and uterine papillary serous carcinoma.. PubMed. 30(9). 3727–30.9 indexed citations
5.
Lindahl, B, et al.. (2009). Adenocarcinoma corpus uteri stage I-II: results of a treatment programme based upon cytometry.. Lund University Publications (Lund University). 29(11). 4731–5.10 indexed citations
Lindahl, B, Jonas Ranstam, & Roger Wïllén. (2007). Prospective malignancy grading of invasive squamous carcinoma of the uterine cervix. Prognostic significance in a long-term follow-up.. PubMed. 27(4C). 2829–32.4 indexed citations
Wïllén, Roger, et al.. (2002). Similarity of uterine mucosa changes in patients treated by raloxifen and tamoxifen.. PubMed. 22(2B). 1121–5.2 indexed citations
11.
Lindahl, B & Roger Wïllén. (1999). Steroid receptor concentrations as a prognostic factor in atypical endometrial hyperplasia.. PubMed. 18(5B). 3793–5.8 indexed citations
12.
Lindahl, B & Roger Wïllén. (1999). Flow cytometry as a prognostic method for the identification of adenomatous hyperplasia at risk of developing endometrial carcinoma.. PubMed. 18(6B). 4611–2.2 indexed citations
13.
Lindahl, B, et al.. (1997). Endometrial carcinoma: results of primary surgery on FIGO stages Ia-Ic and predictive value of histopathological parameters.. PubMed. 17(3C). 2297–302.6 indexed citations
14.
Hemminki, Kari, Hannu Rajaniemi, B Lindahl, & Birgitta Moberger. (1996). Tamoxifen-induced DNA adducts in endometrial samples from breast cancer patients.. PubMed. 56(19). 4374–7.118 indexed citations
Lindahl, B, Mårten Fernö, B Gullberg, A. Norgren, & Roger Wïllén. (1992). 5-year survival rate in endometrial carcinoma stage I-II related to steroid receptor concentration, degree of differentiation, age and myometrial invasion.. PubMed. 12(2). 409–12.5 indexed citations
17.
Lindahl, B & Roger Wïllén. (1991). Endometrial hyperplasia. Clinico-pathological considerations of a prospective randomised study after abrasio only or high-dose gestagen treatment. Results of 2 years follow-up of 292 patients.. PubMed. 11(1). 3007–3018.11 indexed citations
Fernö, Mårten, Alexander Borg, Gy. Horváth, & B Lindahl. (1989). Enzyme immunoassay of progesterone receptor in cancerous and normal endometrial tissue. A comparison with dextran coated charcoal method.. PubMed. 9(6). 1681–3.2 indexed citations
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive
bibliographic database. While OpenAlex provides broad and valuable coverage of the global
research landscape, it—like all bibliographic datasets—has inherent limitations. These include
incomplete records, variations in author disambiguation, differences in journal indexing, and
delays in data updates. As a result, some metrics and network relationships displayed in
Rankless may not fully capture the entirety of a scholar's output or impact.